29Indexed trials
drug · Product Intelligence
Methylphenidate
Pipeline Intelligence
Methylphenidate: 29 indexed trials, 25 sponsors; 0 linked Orange Book patents and 9 FDA-linked events where matched.
25Sponsors
0Orange Book patent links
9FDA-linked events
Development evidence
NCT00012584National Institute of Mental Health (NIMH) · adhdNA
NCT00025779National Institute of Mental Health (NIMH) · autismNA
NCT00136734New York State Psychiatric Institute · adhdPHASE1
NCT00441649Stony Brook University · adhdNA
NCT00536419Federal University of Rio Grande do Sul · adhdPHASE4
NCT00754208University of Nebraska · adhdPHASE4
NCT00773916Federal University of Rio Grande do Sul · adhdPHASE4
NCT00792662University of Nebraska · alzheimersPHASE4
NCT00914095University Hospital, Lille · parkinsonsPHASE4
NCT01040702Shalvata Mental Health Center · adhdPHASE1
NCT01100658University of Minnesota · adhdNA
NCT01238822Children's Hospital Medical Center, Cincinnati · adhdPHASE4
NCT01393574Assaf-Harofeh Medical Center · adhdPHASE4
NCT02178995Kimford Jay Meador · epilepsyPHASE4
NCT02318017Sheba Medical Center · adhdNA
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCOTEMPLA XR-ODT · 2024-08-19
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2020-10-28
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2019-05-23
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2018-11-30
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2017-05-11
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2016-10-21
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2016-02-29
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2015-11-13
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2014-03-12
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.